{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:01:48Z","timestamp":1780120908666,"version":"3.54.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bja.2025.10.023","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T16:31:48Z","timestamp":1763656308000},"page":"20-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vasoplegia and cardiopulmonary bypass: role of oxidation-reduction dysregulation as a mechanism and therapeutic target"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9814-3007","authenticated-orcid":false,"given":"Bruce D.","family":"Spiess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2025.10.023_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13054-018-2102-1","article-title":"Definitions and pathophysiology of vasoplegic shock","volume":"22","author":"Lambden","year":"2018","journal-title":"Critical Care"},{"key":"10.1016\/j.bja.2025.10.023_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14797\/mdcvj.1245","article-title":"Vasoplegia: a review","volume":"19","author":"Ratnani","year":"2023","journal-title":"Methodist DeBakey Cardiovasc J"},{"key":"10.1016\/j.bja.2025.10.023_bib3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13054-018-1967-3","article-title":"Vasoplegia treatments: the past, the present, and the future","volume":"22","author":"Levy","year":"2018","journal-title":"Critical Care"},{"key":"10.1016\/j.bja.2025.10.023_bib4","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bja.2025.05.026","article-title":"Hydroxocobalamin for vasoplegia in cardiac surgery: a retrospective cohort analysis","volume":"135","author":"Zakaria","year":"2025","journal-title":"Br J Anesth"},{"key":"10.1016\/j.bja.2025.10.023_bib5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.jvca.2018.08.017","article-title":"Hydroxocobalamin for the treatment of vasoplegia: a review of current literature and considerations for use","volume":"33","author":"Shapeton","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bja.2025.10.023_bib6","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1053\/j.jvca.2023.08.145","article-title":"Intraoperative versus postoperative hydroxocobalamin for vasoplegic shock in cardiothoracic surgery","volume":"37","author":"Khandekar","year":"2023","journal-title":"J Cardiothoracic Vasc Anesth"},{"key":"10.1016\/j.bja.2025.10.023_bib7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.jvca.2025.02.001","article-title":"Use of hydroxocobalamin in the prevention of vasoplegic syndrome in adult patients undergoing cardiopulmonary bypass: a controlled prospective trial","volume":"39","author":"Salah","year":"2025","journal-title":"J Cardiothoracic Vasc Anesth"},{"key":"10.1016\/j.bja.2025.10.023_bib8","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1053\/j.jvca.2023.04.006","article-title":"Hydroxocobalmain for vasodilatory hypotension in shock: a systematic review with meta-analysis for comparison to methylene blue","volume":"37","author":"Brokmeier","year":"2023","journal-title":"J Cardiothoracic Vasc Anesth"},{"key":"10.1016\/j.bja.2025.10.023_bib9","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1053\/j.jvca.2023.07.015","article-title":"Hydroxocobalamin versus methylene blue for the treatment of vasoplegic shock associated with cardiopulmonary bypass","volume":"37","author":"Hiruy","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bja.2025.10.023_bib10","article-title":"Intravenous vitamin C for vasoplegia: a double-blinded randomized clinical trial (VALENCIA Trial)","volume":"78","author":"Amstey","year":"2023","journal-title":"J Crit Care"},{"key":"10.1016\/j.bja.2025.10.023_bib11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.bja.2025.01.015","article-title":"EACTS\/EACTAIC\/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery","volume":"134","author":"Wahba","year":"2025","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.10.023_bib12","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1097\/TA.0000000000000740","article-title":"Pre-clinical evaluation of injectable reduced hydroxocobalamin as an antidote to acute carbon monoxide poisoning","volume":"78","author":"Roderique","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.bja.2025.10.023_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tox.2015.05.004","article-title":"A modern literature review of carbon monoxide poisoning theories, therapies, and potential targets for therapy advancement","volume":"334","author":"Roderique","year":"2015","journal-title":"Toxicology"},{"key":"10.1016\/j.bja.2025.10.023_bib14","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.athoracsur.2013.08.050","article-title":"The use of high-dose hydroxocobalamin for vasoplegic syndrome","volume":"97","author":"Roderique","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bja.2025.10.023_bib15","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.burns.2021.10.017","article-title":"Cost impact of hydroxocobalamin in the treatment of patients with known or suspected cyanide poisoning due to smoke inhalation form closed-space fires","volume":"48","author":"Sanders","year":"2022","journal-title":"Burns"},{"key":"10.1016\/j.bja.2025.10.023_bib16","first-page":"1231","article-title":"Sulfur dioxide: foe or friend for life?","volume":"32","author":"Wang","year":"2017","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.bja.2025.10.023_bib17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/bja\/aep018","article-title":"Effects of phenylephrine on the sublingual microcirculation during cardiopulmonary bypass","volume":"102","author":"Maier","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.10.023_bib18","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jtcvs.2015.09.071","article-title":"Cardiopulmonary bypass and the endothelial glycocalyx: shedding new light","volume":"150","author":"Kausja","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bja.2025.10.023_bib19","first-page":"H550","article-title":"Impaired microcirculatory perfusion in a rat model of cardiopulmonary bypass: the role of hemodilution","volume":"310","author":"Konig","year":"2016","journal-title":"Am J Physiolog"},{"key":"10.1016\/j.bja.2025.10.023_bib20","first-page":"1474","article-title":"Perturbation of the microvascular glycocalyx and perfusion in infants after cardiopulmonary bypass","volume":"150","author":"Nussbaum","year":"2015","journal-title":"J Cardiothoracic Cardiovasc Surg"},{"key":"10.1016\/j.bja.2025.10.023_bib21","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1161\/CIRCULATIONAHA.104.531152","article-title":"Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting","volume":"112","author":"Tomic","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bja.2025.10.023_bib22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1055\/s-0038-1649929","article-title":"Individual variations in the fibrinolytic response during and after CPB","volume":"74","author":"Chandler","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bja.2025.10.023_bib23","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/s41598-020-59983-4","article-title":"Cysteine redox state regulates human B2-adrenergic receptor binding and function","volume":"10","author":"Rambacher","year":"2020","journal-title":"Sci Reps"},{"key":"10.1016\/j.bja.2025.10.023_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.freeradbiomed.2016.04.023","article-title":"Post-translational oxidative modification of fibrinogen is associated with coagulopathy after traumatic injury","volume":"96","author":"White","year":"2016","journal-title":"Free Rad Biol Med"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091225007433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091225007433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:25:23Z","timestamp":1780118723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091225007433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0007091225007433"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2025.10.023","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasoplegia and cardiopulmonary bypass: role of oxidation-reduction dysregulation as a mechanism and therapeutic target","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2025.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2025.05.026","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}